Deoxycholic Acid
-
Subject Areas on Research
- A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
- A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.
- A fine line between molecular umbrella transport and ionophoric activity.
- Advances in the treatment of invasive neonatal candidiasis.
- Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis.
- Antifungal therapy and outcomes in infants with invasive Candida infections.
- Bile salts stimulate glycoprotein release by guinea pig gallbladder in vitro.
- Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
- Creation and properties of histocompatibility antigen-cell conjugates. I. Preparation and immunological properties of rat histocompatibility antigens.
- Cryptococcal meningoencephalitis: time for action.
- Deoxycholate induces the preferential hydrolysis of polyphosphoinositides by human platelet and rat corneal phospholipase C.
- Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
- Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.
- Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination.
- Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
- Hepatic sulfite oxidase. Congruency in mitochondria of prosthetic groups and activity.
- Management of invasive mycoses in hematology patients: current approaches.
- Neonatal candidiasis: prophylaxis and treatment.
- Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
- Phase-lifetime spectrophotometry of deoxycholate-purified bacteriorhodopsin reconstituted into asolectin vesicles.
- Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei.
- Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
- Recurrent Xanthelasmas Treated With Intralesional Deoxycholic Acid.
- Use of newer antifungal therapies in clinical practice: what do the data tell us?